Clinical trial
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who…
NCT00395720 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00395720 |
|---|---|
| Title | The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV |
| Official title | A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Healthy Volunteers Who Are Infected With HIV |
| Lead sponsor | University of Oxford, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tuberculosis, HIV Infections |
| Intervention type | Biological |
| Interventions | MVA85A (TB vaccine), MVA 85A |
| Enrollment | 20 |
| Start date | Nov 1, 2006 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Nov 3, 2006 |
| Last update posted | Mar 28, 2011 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: